Tech Company Financing Transactions
Apoptos Funding Round
Apoptos, based in San Diego, secured $28 million in investment from Advanced Technology Ventures, Arch Venture Partners and OrbiMed.
Transaction Overview
Company Name
Announced On
5/6/2008
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series A
Investors
Proceeds Purpose
The financing will fund the company through 2010. It will be used to advance Apoptos' portfolio of small molecule drugs that are directed at inducing tumor cell apoptosis, also known as programmed cell death.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10835 Rd. to the Cure 205
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Apoptos Inc. is focused on developing novel small molecule drug therapies that directly induce tumor cell apoptosis. Apoptos is pioneering its anticancer platforms in close collaborations with preeminent scientists in the fields of apoptosis and experimental cancer therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Rastetter
Co-Founder
Marcus Boehm
Co-Founder
Robert Peach
Browse more venture capital transactions:
Prev: 5/6/2008: PurePlay venture capital transaction
Next: 5/6/2008: Cardiva Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs